A new study out of the UK suggests the first dose of the Pfizer-BioNTech COVID-19 vaccine could significantly protect against asymptomatic infection. Researchers tested daily thousands of healthcare ...
(Reuters) – The first dose of Pfizer Inc and BioNTech’s COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet https ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback